Most bought healthcare stocks in Q1 2021
See which Healthcare stocks institutional investors increased the most in Q1 2021, measured as net growth in reported share positions from Q4 2020 into Q1 2021. Notable additions at the top of this list include SANOFI-ADR (SNY), BAUSCH HEALTH COS INC (BHC), NUVATION BIO INC (NUVB), TAKEDA PHARMACEUTIC-SP ADR (TAK). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| SNY | SANOFI-ADR | 29,278,692 | $1.48B | 3 | 4 | 1 | 0 | 9 |
| BHC | BAUSCH HEALTH COS INC | 27,619,948 | $1.18B | 1 | 2 | 3 | 1 | 7 |
| NUVB | NUVATION BIO INC | 12,584,534 | $117.94M | 3 | 0 | 0 | 0 | 3 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 8,103,431 | $149.36M | 0 | 3 | 1 | 0 | 5 |
| AVTR | AVANTOR INC | 6,832,263 | $217.69M | 2 | 2 | 1 | 0 | 6 |
| TDOC | TELADOC HEALTH INC | 6,579,042 | $1.05B | 1 | 6 | 0 | 1 | 7 |
| OSCR | OSCAR HEALTH INC - CLASS A | 5,559,990 | $149.45M | 1 | 0 | 0 | 0 | 1 |
| BFLY | BUTTERFLY NETWORK INC | 5,289,325 | $89.02M | 2 | 0 | 0 | 0 | 2 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 4,604,818 | -$78.39M | 1 | 2 | 1 | 0 | 4 |
| FATE | FATE THERAPEUTICS INC | 4,527,009 | $342.56M | 0 | 3 | 1 | 0 | 4 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 4,188,116 | $189.11M | 0 | 3 | 1 | 3 | 6 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3,770,320 | $144.45M | 2 | 3 | 3 | 1 | 8 |
| BEAM | BEAM THERAPEUTICS INC | 3,684,581 | $293.10M | 1 | 1 | 1 | 0 | 3 |
| ACCD | ACCOLADE INC | 3,644,439 | $170.99M | 0 | 2 | 0 | 1 | 2 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,352,249 | $108.95M | 1 | 0 | 0 | 0 | 1 |
| GILD | GILEAD SCIENCES INC | 3,248,177 | $426.08M | 0 | 11 | 1 | 2 | 14 |
| EXAS | EXACT SCIENCES CORP | 3,170,065 | $414.56M | 0 | 5 | 2 | 0 | 7 |
| TXG | 10X GENOMICS INC-CLASS A | 2,848,911 | $547.05M | 1 | 4 | 0 | 1 | 5 |
| ATOS | ATOSSA THERAPEUTICS INC | 2,811,340 | $6.50M | 0 | 1 | 0 | 0 | 1 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | 2,748,760 | $93.92M | 0 | 1 | 0 | 0 | 1 |
| IONS | IONIS PHARMACEUTICALS INC | 2,576,360 | $79.40M | 0 | 1 | 3 | 0 | 5 |
| ALHC | ALIGNMENT HEALTHCARE INC | 2,464,107 | $52.85M | 2 | 0 | 0 | 0 | 2 |
| CDXS | CODEXIS INC | 2,319,511 | $57.29M | 0 | 1 | 0 | 0 | 1 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 2,226,430 | $194.14M | 3 | 3 | 5 | 0 | 12 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 2,089,020 | -$511.14M | 1 | 2 | 0 | 0 | 4 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,835,560 | $71.70M | 1 | 0 | 0 | 0 | 1 |
| PGEN | PRECIGEN INC | 1,832,881 | -$11.60M | 0 | 1 | 1 | 0 | 2 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,635,223 | $93.06M | 0 | 4 | 0 | 0 | 4 |
| THC | TENET HEALTHCARE CORP | 1,498,713 | $79.15M | 1 | 1 | 0 | 0 | 2 |
| ACHC | ACADIA HEALTHCARE CO INC | 1,289,591 | $77.07M | 0 | 1 | 1 | 0 | 2 |
| INCY | INCYTE CORP | 1,288,989 | $43.90M | 0 | 4 | 2 | 0 | 7 |
| SDGR | SCHRODINGER INC | 1,256,816 | $71.67M | 1 | 1 | 1 | 0 | 4 |
| TMO | THERMO FISHER SCIENTIFIC INC | 1,253,896 | $580.51M | 0 | 8 | 6 | 0 | 17 |
| BDX | BECTON DICKINSON AND CO | 1,169,452 | $199.54M | 1 | 8 | 6 | 3 | 17 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 1,135,000 | $12.27M | 0 | 1 | 0 | 0 | 1 |
| NKTR | NEKTAR THERAPEUTICS | 1,000,000 | $20.34M | 1 | 0 | 0 | 0 | 2 |
| CTXR | CITIUS PHARMACEUTICALS INC | 967,819 | $1.74M | 0 | 1 | 0 | 0 | 1 |
| SYK | STRYKER CORP | 907,056 | $209.08M | 0 | 7 | 3 | 0 | 12 |
| ZLAB | ZAI LAB LTD-ADR | 824,117 | $109.89M | 2 | 0 | 0 | 0 | 3 |
| IQV | IQVIA HOLDINGS INC | 764,102 | $176.70M | 1 | 1 | 2 | 1 | 5 |
| SENS | SENSEONICS HOLDINGS INC | 763,000 | $3.83M | 0 | 1 | 0 | 0 | 1 |
| RPTX | REPARE THERAPEUTICS INC | 723,196 | $19.90M | 0 | 1 | 0 | 0 | 1 |
| PODD | INSULET CORP | 720,541 | $193.98M | 1 | 3 | 1 | 1 | 5 |
| NOTV | INOTIV INC | 681,165 | $13.62M | 1 | 0 | 0 | 0 | 1 |
| MODV | MODIVCARE INC | 677,499 | $100.35M | 1 | 0 | 0 | 0 | 1 |
| NVAX | NOVAVAX INC | 676,387 | $125.64M | 1 | 1 | 1 | 0 | 3 |
| MASS | 908 DEVICES INC | 635,618 | $27.13M | 0 | 1 | 0 | 0 | 1 |
| PFE | PFIZER INC | 616,056 | $40.34M | 1 | 12 | 6 | 1 | 19 |
| ABT | ABBOTT LABORATORIES | 596,257 | $336.31M | 1 | 3 | 8 | 0 | 16 |
| SEER | SEER INC | 578,042 | $27.26M | 1 | 0 | 0 | 1 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q1 2021
What are the most bought Healthcare stocks in Q1 2021?
The most bought healthcare stocks in Q1 2021 are those with the largest increase in reported share counts across institutional investors compared to Q4 2020, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2021?
Among filers in this sector, net additions were largest in companies such as SANOFI-ADR (SNY), BAUSCH HEALTH COS INC (BHC), NUVATION BIO INC (NUVB), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2020).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.